Research map: Aspirin discontinuation after percutaneous coronary intervention for acute coronary syndromes

Back to the article

Papers in this map

  1. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials · Marco Valgimigli · 2024 · 108 citations · Cited by this paper
  2. Survival following aortic valve surgery for prosthetic valve endocarditis: a SWEDEHEART study · 2026 · Related
  3. P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials · Daniele Giacoppo · 2025 · 48 citations · Cited by this paper
  4. Beyond diameter: emerging imaging biomarkers for risk stratification in thoracic aortic aneurysms · 2026 · Related
  5. Antithrombotic Therapy in High Bleeding Risk, Part I · Mattía Galli · 2024 · 41 citations · Cited by this paper
  6. Stroke after transcatheter aortic valve implantation: the limits of progress · 2026 · Related
  7. Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study · Neel M. Butala · 2021 · 28 citations · Cited by this paper
  8. Comparison between three single-dose cardioplegic solutions in myocardial protection: Cardioplegia Trial – a double-blind randomised clinical trial · 2026 · Related
  9. Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease? · Mattía Galli · 2025 · 18 citations · Cited by this paper
  10. Response to: Correspondence on ‘When a patent foramen ovale becomes pathological’ by Calcaterra et al · 2026 · Related
  11. Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials · Felice Gragnano · 2026 · 10 citations · Cited by this paper
  12. Atypical respiratory variation: trace to massive tricuspid regurgitation · 2026 · Related
  13. Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology · Diana Adrienne Gorog · 2026 · 4 citations · Cited by this paper
  14. Refining evidence-based care for diverse bicuspid aortic valve phenotypes: addressing one piece of a larger puzzle · 2026 · Related
  15. Optimal timing of aspirin discontinuation after acute coronary syndrome treated with percutaneous coronary intervention: a systematic review and meta-analysis · Kamil Bujak · 2026 · 3 citations · Cited by this paper
  16. Feasibility of early double sequential defibrillation in out-of-hospital cardiac arrest: the double-D randomised pilot trial · 2026 · Related
  17. Premature ventricular contractions burden and long-term ventricular remodelling in patients without structural heart disease · 2026 · Related
  18. Generalisable artificial intelligence ECG trained on public data for outcome prediction after transcatheter aortic valve replacement · 2026 · Related

Source: OpenAlex (CC0)